Top Biotech Companies in Montreal (24)
At Ventus, we are pioneering a unique approach to structure-based drug discovery to address biologically validated, but difficult-to-drug targets. Others are building towards a future transformation of the drug development process … for Ventus, that future is already here. Our ReSOLVE™ platform integrates cutting-edge, structurally enabled, computational tools to identify and perfect new drug molecules for targets which have never been drugged...
ALTEN Technology USA is an engineering consulting company that provides innovative solutions for engineering, IT, and product development projects across the product life cycle. For decades, ALTEN Technology USA has been helping clients develop products that are changing the world, whether by shaping the future of space exploration, saving lives with medical devices that set new standards of care or...
Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions. We have a strong track record, having advanced multiple vaccines from early R&D to approvals,...
Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. The nELISA was designed to seamlessly integrate into current workflows in biology and is uniquely adaptable to a wide...
Ashfield Advisory is a business unit that provides integrated advisory and consulting services to the healthcare industry, leveraging an ecosystem of specialized businesses for insight, strategy, and action.
Perceiv is a precision medicine company unlocking the potential of medical data and deep learning to optimize diagnosis and prognosis. Our mission is to improve the effectivenes of treatment by identifying the right patients that will benefit from a particular treatment. Our platform is used in situations in which precise decisions are required over heterogeneous populations such as precision medicine...
The multinational Duchesnay with its affiliated companies is headquartered in Blainville, Quebec. The group consists of five pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad: - Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health; - Médunik Canada and Medunik USA, which provide treatments for rare diseases; and - Analog Pharma, an American generic drugs company,...
Located in Montreal, Inversago Pharma is a privately-owned Canadian biotech company at clinical-stage, specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting, CB1 inverse agonists. The Company aims to provide new treatment options that improve the lives of patients affected by metabolic conditions such as Diabetic Kidney Disease (DKD), including Diabetic Nephropathy, Type 1...
Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and the environment safer, healthier and more sustainable. From the food you eat to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe,...
Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and...
Sandoz's Top Stability & Growth Strengths
Strong Market Position & Advantage: Sandoz is widely characterized as a global leader in biosimilars and a top‑tier generics player, with multiple first‑to‑market and leading‑share launches (e.g., ustekinumab, denosumab) that reinforce competitive strength. Partnerships and European scale further underpin its standing across high‑value biologic categories.
Strong Revenue Growth: Reported net sales increased in 2024 and 2025, with biosimilars contributing strongly and rising as a share of sales. Guidance for 2026 indicates mid‑ to high‑single‑digit growth at constant currency, signaling continued top‑line momentum.
Profitability: Core EBITDA margins expanded in 2024 and 2025 alongside improvements in management free cash flow and ROIC. Guidance points to additional margin expansion in 2026 supported by a higher biosimilar mix and operational initiatives.
Congruence is a computationally-driven biotechnology company building a unique pipeline of transformative small molecule correctors rationally designed to rescue aberrant protein function. Our proprietary scalable platform, Revenir™, captures the biophysical features of proteins across their conformational ensembles, in order to identify novel allosteric and cryptic pockets which are virtually screened to generate novel chemical matter.
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes across oncology, neurology and cardiology. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years.
Lantheus's Top Stability & Growth Strengths
Strong Market Position & Advantage: PYLARIFY is described as the leading PSMA PET agent in the U.S., and DEFINITY is the most utilized ultrasound contrast agent, underscoring category leadership. Management’s 2026 plan emphasizes sustaining PSMA PET leadership and leveraging a broad manufacturing and distribution network.
Diversified Revenue Streams: Portfolio expansion into Alzheimer’s PET via NEURACEQ adds a second commercial PET pillar alongside PSMA and echocardiography contrast. Recent acquisitions and the SPECT divestiture concentrate the company around multiple higher‑growth PET diagnostics.
Future-Ready Strategy: FDA clearance of PYLARIFY TruVu with a phased 4Q26 launch is framed to expand capacity and strengthen supply. Management points to late‑stage catalysts and execution in 2026 as enablers of growth reacceleration from 2027.
Cancer doesn’t wait — so we shouldn’t either. At Avitia, we’re making sure that clinical labs and oncologists everywhere have the tools they need to diagnose, as well as treat cancer faster. Our AI/ML technology ensures partners have cost-effective NGS-based molecular testing solutions that provide rapid turnaround times. Now, we empower healthcare teams to skip the delays and focus on...
Valence Labs, powered by Recursion, is industrializing scientific discovery to radically improve lives. Our vision is that highly autonomous systems capable of Nobel-worthy insights will usher in a new wave of scientific discovery. Following the acquisition of Valence Discovery by Recursion (NASDAQ: RXRX) in May 2023, Valence Labs continues as a semi-autonomous AI research engine within Recursion aiming to advance...
Xcenda’s strategic consulting and field reimbursement services help pharmaceutical and biotech manufacturers thrive in global, value-driven healthcare markets. Our areas of expertise include health economics and outcomes research, reimbursement and global market access strategy, market research, and health policy analysis, as well as the development of value demonstration tools, scientific publications, training programs and outsourced field reimbursement teams. We apply...
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals...
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and...
Elekta's Top Stability & Growth Strengths
Strong Market Position & Advantage: Elekta is a top-tier radiotherapy vendor with category leadership in cranial stereotactic radiosurgery and a notable presence in high-field MR-guided therapy, reinforcing durable competitive standing. Recognition for oncology information systems further supports its positioning in cancer centers.
Innovation-Driven Growth: Recent launches such as Elekta Evo and the Elekta ONE software suite, alongside continued advancement of Unity MR‑Linac workflows, indicate a pipeline that is aiding orders and improving mix. These innovations underpin adaptive and image‑guided therapy strategies across the portfolio.
Resilient & Sustainable Growth: Book‑to‑bill ratios above 1.0 and low single‑digit constant‑currency sales growth point to steady underlying expansion. Improving adjusted margins in recent quarters suggest operational gains despite macro headwinds.
CECO Environmental is a global leader in air quality and fluid handling serving the energy, industrial and other niche markets. Providing innovative technology and application expertise, CECO helps companies grow their business with safe, clean and more efficient solutions that help protect our shared environment. In regions around the world, CECO works to improve air quality, optimize the energy value...
Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical...


































